Suicide Prevention in Schizophrenia, Obstacles and Awareness
Younger age is associated with being a risk for suicide in patients with schizophrenia, due to the onset of the disease more than age, according to researchers.
Features
FEATURES
Latest Features
Schizophrenia, Bipolar Disorder, and the Psychosis Continuum
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Understanding CBD: How to Advise Patients About Existing Laws, Clinical Evidence, and More
At Psych Congress 2018, Andrew Penn from the UCSF School of Nursing provides insight into the use of CBD in clinical practice.
Drug-Free Chronotherapies Represent Unique Treatments for Depression
Researchers found that bright light therapy is a suitable option for those who must avoid antidepressant medications, such as individuals who are in perinatal and geriatric populations.
Insulin Resistance in Schizophrenia Occurs With and Without Antipsychotics
Researchers found data that showed patients with schizophrenia have an increased risk for metabolic disorders, and aripiprazole, lurasidone, and ziprasidone may offer the lowest risk for weight gain.
Is There a Link Between Drugs for Parkinson Disease and Gambling Disorders?
Pathological gambling was recently identified as a complication of Parkinson disease and its pharmacological treatment, especially high-dose dopaminergic agonists.
Medical Assistance in Dying: Ongoing Challenges for Psychiatrists
With more states passing bills allowing physician-assisted suicide, psychiatrists are reflecting on their roles in the process and responsibilities to their patients.
Updated 2019 VA/DoD Clinical Practice Guidelines for Managing Suicide Risk
A workgroup convened by the US Department of Veteran Affairs and US Department of Defense released updated joint clinical practice guidelines with the goal of reducing the incidence of suicide through screening and evaluation of patients identified with elevated risk.
Improving Detection of Delirium in the Acute Setting
Delirium is highly prevalent in critical care, especially among elderly patients and individuals with dementia. Although rates vary widely across studies, findings suggest delirium affects more than 15% of hospitalized patients. For additional discussion regarding this topic, Neurology Advisor interviewed Leopoldo Pozuelo, MD, MBA, FACP, FACLP, clinical vice chair of psychiatry and psychology at the Cleveland Clinic in Ohio.
Schizophrenia vs Psychosis Spectrum Disorder as a Diagnosis
Psychosis spectrum disorder as a diagnosis in place of schizophrenia remains controversial, and experts suggest confusion will continue.
How Gratitude Can Help Resolve Ethical Dilemmas
Gratitude may be a valuable tool that helps clinicians to develop “moral clarity” by improving the quality of their thought processes.
Should Aging Physicians Be Required to Undergo Cognitive Testing?
The issue of aging physicians poses serious challenges to the medical profession, with concerns that judgment or skills might decline with age.
Clozapine Cardiotoxicity: A Compendium for Psychiatry Clinicians
The authors discuss the rare but potentially life-threatening cardiovascular adverse effects of dilated cardiomyopathy and myocarditis linked to the use of clozapine.
Could Summer Depression Be Seasonal Affective Disorder?
Although winter is most commonly associated with seasonal affective disorder, some people experience SAD during the summertime.
Do Your Patients Consult Google Before They Consult You? An Expert Interview
A 2013 Pew Research Center and Internet Life Project report found that 59% of US adults said that they turned to the Internet regarding a health problem during the past year.
Can a Ketogenic Diet Benefit Patients With Mental Health Disorders?
A review of research reveals that a while ketogenic diet may hold some promise for individuals with mental health disorders, additional studies are necessary.
ACP Releases Policy Statement on DOI, COI Management for Clinical Guideline Development
The American College of Physicians endorses the necessity of a comprehensive process for disclosure of potential conflicts of interest to ensure the integrity of clinical guidelines and guidance statements.
Post-ICU Syndrome: Identifying Challenges and Improving Mortality
Post-ICU syndrome includes psychological effects — depression, anxiety, and PTSD — as well as worsened physical functioning.
EMDR: A Rapidly Expanding Modality for Treating Mental Health Disorders
After 30 years, eye movement desensitization and reprocessing (EMDR) therapy continues to gain support as a beneficial treatment for a wide range of mental health conditions, especially post-traumatic stress disorder.
Obsessive-Compulsive Symptoms in Schizophrenia: A Clinical and Therapeutic Review
Researchers found data that showed obsessive compulsive symptoms in patients with schizophrenia are linked to poor outcomes.
Treatment Recommendations for Major Depressive Disorder in Medical Illness
Major depressive disorder (MDD) is commonly observed in medical settings, with a prevalence of up to 14% compared with 2% to 4% in the general population.1 Various studies have found rates of 12% to 18% in patients with diabetes, 15% to 23% in those with coronary heart disease, 23% to 54% in patients with multiple…
Interventions for Improving Longevity in Those With Schizophrenia
Researchers found data that showed in addition to genetic factors, self-managed behaviors, such as diet, play a large role in longevity in patients with schizophrenia.
Ketamine Changes Course of Major Depressive Disorder Treatment
Currently, there is an unmet need for the development of rapid-acting antidepressants aimed at treatment-resistant patients with either major depressive disorder (MDD) or bipolar disorder. A review of existing treatment options, as well as future possibilities, was published in Psychiatry and Clinical Neurosciences.1 Approximately 320 million people worldwide are affected by MDD, with a noted…
The Link Between Misconceptions About Opioid Use Disorders and Current Policies
An estimated 20 million people in the United States meet the criteria for substance use disorder.
Improving Physician Comfort With Treating Transgender Patients
Estimates indicate that ~1.4 million people self-identify as transgender in the United States, which is double the initial estimate is made by the Williams Institute in 2011.
Depression With Autism: Effective Diagnosis and Treatment
Researchers found data that showed patients with autism may not express their emotions in relation to depression, so psychiatrists should enlist the help of those who are familiar with the patient.
Auditory Hallucinations in Schizophrenia
Interventions for auditory hallucinations in schizophrenia should be coordinated with patients to fit their needs.
Exploring the Value of Peer Support for Mental Health
Peer support is recognized by such bodies as the Substance Abuse and Mental Health Services Administration and the American Psychiatric Association as a valuable component of recovery-oriented services within systems of care.
Using Digital Therapeutics to Treat Substance Use Disorders
The convenience and confidentiality of computer-based and mobile technologies may encourage more individuals with substance use disorders to access treatment.
The Asthma-Mental Health Connection: Expert Clinicians Weigh In
Patients with asthma have demonstrated an elevated risk for depression and anxiety that is potentially twice as high as that in the general population.
A Contemporary Review of Praecox in Schizophrenia
Researchers found data that show praecox feeling is objective because it is based on the patient’s behaviors and body language.
Treatments for Resynchronization in Sleep and Depression
Researchers found data that show adverse lifestyle factors increase the risk for depression.
Cannabis-Induced Psychosis in Teenagers and Young Adults: Risk Factors, Detection, Management
An increasing number of adolescents and young adults use cannabis for recreational or medicinal purposes, unaware that potential adverse effects include psychosis.
Sensible Strategies to Overcome Barriers to Depression Treatment
Researcher data showed that the boundaries to successful treatment in depression in patients who are minorities are varied, but that there are certain predisposing factors such as adverse childhood events and genetics.
Metacognitive Interventions for Delusions in Schizophrenia
Researchers in Germany found that metacognitive intervention is effective in schizophrenia, specifically for patients with schizophrenia who make quick conclusions with their thoughts that in turn reinforce their delusions. They have created and implemented the use of a computer application to facilitate metacognitive intervention, which they believe is effective for patients with mental illness.
Expert Roundtable: A Close Look at Suicide “Contagion”
The number of deaths by suicide in spring 2019 highlighted the ripple effects of violence and sparked reports that a phenomenon called “suicide contagion” may have been a contributing factor in these incidents.
Health Technology Designed to Engage With Depressive Disorders
Researchers discovered that self-management strategies through the use of mobile applications improves adherence to medications with reminders and messages of support.
Are Injectable Antipsychotics Effective in Managing Schizophrenia?
Researchers found data that showed in patients with schizophrenia, long-acting injectable antipsychotics are preferred and patients feel better supported in their illness.
Treatment Nonadherence in Schizophrenia: The Patient’s Perspective
Researchers found that there a many factors that contribute to nonadherence to antipsychotic medication in patients with schizophrenia, including the patient’s perception that the physician is in alliance with their family, rather than listening to what he or she wants. Physicians who were interviewed by Psychiatry Advisor recommend listening to what is important to the patient. Weight gain associated with medications might be unacceptable to some patients, or medication-induced somnolence, which to some could be intolerable, might help severe insomnia in others.
New AAN Guideline: Treating Tourette Syndrome and Other Chronic Tic Disorders
An expert subcommittee of the AAN has released an updated evidence-based clinical practice guideline on treating Tourette syndrome and other chronic tic disorders.
Want to read more?
Please login or register first to view this content.